BANGKOK, Thailand: The U.S. Food and Drug Administration’s (FDA) decision authorizing the sale of Philip Morris International (PMI)’s heated tobacco system, IQOS, in the United States inadvertently puts a foot in the door to increase sales of new tobacco products in the developing world.
In April this year, the FDA authorized the sale of IQOS heated tobacco products in the US. However, it clarified that it has not approved IQOS as a ‘modified risk tobacco product’ (MRTP). But PMI is riding on this ‘US-FDA approved for sale’ of its IQOS as also safer alternative to regular cigarettes to Asian governments.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.